1. Combination therapy with ruxolitinib plus intensive treatment strategy is feasible in patients with blast‐phase myeloproliferative neoplasms. (10th June 2015) Authors: Devillier, Raynier; Raffoux, Emmanuel; Rey, Jérôme; Lengline, Etienne; Ronchetti, Anne‐Marie; Sebert, Marie; Boissel, Nicolas; Robin, Marie; Vey, Norbert; Kiladjian, Jean‐Jacques; Dombret, Herve; Cluzeau, Thomas Journal: British journal of haematology Issue: Volume 172:Number 4(2016) Page Start: 628 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗